Spark Therapeutics Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
M****
?
U****************
Kontra
?
A****************
?
W******* i* V********
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| United Therapeutics | -1,86 % | -1,66 % | 13,58 % | 61,04 % | 8,24 % | 123,11 % | 223,43 % |
| Iovance Biotherapeutics Inc. | 0,89 % | -19,52 % | 44,97 % | 2,34 % | 41,34 % | -44,71 % | -87,18 % |
| Ligand Pharmaceuticals | -0,55 % | 0,00 % | 13,66 % | 83,00 % | 10,24 % | 191,77 % | 40,61 % |
Kommentare
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December